Professional
Added to YB: 2024-09-06
Pitch date: 2024-06-30
ABT [bullish]
Abbott Laboratories
-4.44%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$163.9B
Pitch Price
$100.07
Price Target
N/A
Dividend
2.68%
EV/EBITDA
15.77
P/E
26.36
EV/Sales
4.24
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Diamond Hill Select Fund New Position: Abbott Laboratories
ABT: Diversified healthcare co. w/ strong intl. presence (40% from emerging mkts). Solid growth prospects, skilled mgmt in capital allocation. Strategic moves: Euro generics divestiture (2014), St. Jude acquisition (2016). Portfolio spans devices, pharma, nutrition, diagnostics.
Read full article (1 min)